Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar By: CNBC.com News August 08, 2024 at 07:02 AM EDT The success of Eli Lilly's weight loss and diabetes drugs Zepbound and Mounjaro caused the company to hike its guidance. Read More >>
